Stroke/Cerebrovascular Disease News

• Walking Fast May Help Prevent Type 2 Diabetes An analysis indicates that patients with fairly brisk walking are at a 24% lower risk for type 2 diabetes than those with easy or casual walking.
  Medscape Medical News, December 22, 2023
• No Impact of Race on Cardiovascular Risk Calculations A recent study adds to the growing body of evidence questioning the role of race-based stratification for specific clinical measures.
  Medscape Medical News, December 20, 2023
• Female Patients With PCI Benefit From Abbreviated DAPT Women undergoing percutaneous coronary intervention who receive abbreviated rather than standard dual antiplatelet therapy have similar outcomes to men despite higher baseline risk.
  Medscape Medical News, December 20, 2023
• Reducing CVD Morbidity and Mortality in Psoriasis and PsA Only a minority of patients with psoriatic disease know about their increased risks.
  MDedge News, December 20, 2023
• Patients Facing Death Are Choosing a Lifesaving Heart Device The HeartMate 3 is considered the safest mechanical heart pump of its kind, but a federal database has more than 4500 reports in which the medical device may have caused a patient's death.
  KFF Health News, December 20, 2023
• Infection Main Cause of Nonrelapse Death With CAR T Therapy Infections, cardiopulmonary disease, and second cancers were among the leading causes of nonrelapse deaths in patients receiving CAR T-cell therapy, both in clinical trials and clinical practice.
  Medscape Medical News, December 19, 2023
• GLP-1s Face Off Against Each Other, Weight-Loss Surgery New comparison studies show the popular weight-loss medications might not reduce certain complications as well as surgical interventions, but there's still plenty of positive news surrounding them.
  Medscape Medical News, December 19, 2023
• Catheter-Directed Plan Improves Pulmonary Artery Occlusion The Bashir endovascular catheter was designed to maximize thrombus reduction via a pharmacomechanical infusion.
  MDedge News, December 18, 2023
• Subhairline EEG: Potential for LVO Stroke Detection Unlocked Utilizing user-friendly, swiftly applicable electrodes, subhairline EEG may improve stroke detection and reduce time to treatment for anterior circulation large vessel occlusion stroke.
  Medscape Medical News, December 18, 2023
• What Causes Obesity? More Science Points to the Brain In the battle against obesity, one crucial organ has been long overlooked.
  WebMD Health News, December 15, 2023
• GLP-1 RAs for CVD: Are Cardiologists Ready? The SELECT trial catapulted GLP-1 RAs into the forefront of CVD prevention, but cardiologists are making their own decisions about whether and how they might integrate these agents into practice.
  Medscape Medical News, December 14, 2023
• Tafamidis May Help Protect Cardiac Function in ATTR-CM Patients with transthyretin amyloid cardiomyopathy taking tafamidis have less worsening of cardiac function than those on placebo, post hoc analysis of randomized results suggests.
  Medscape Medical News, December 14, 2023
• Sharp Rise in Traumatic Brain Injury-Related Mortality The number of TBI-related deaths in the US increased 22% between 2010 and 2020, with the largest rise in individuals aged 75 and older, a new study shows.
  Medscape Medical News, December 14, 2023
• SCD Mortality Rates Improved for Black Patients in 2010s The average age of death for Black US patients with sickle cell disease rose from 39 years in 1999-2009 to 43 years in 2010-2020, reflecting improvements in treatment.
  MDedge News, December 14, 2023
• Stem Cell Therapy Implant Shows Promise for Type 1 Diabetes An experimental device containing millions of stem cells significantly reduced the need for insulin shots among people with type 1 diabetes.
  WebMD Health News, December 12, 2023
• Exercise Plan Cost-Effective in Post-Stroke Cognitive Rehab An exercise program improved cognitive scores and yielded cost savings, according to a recent study, but showed limited effects on health-related quality of life.
  Medscape Medical News, December 12, 2023
• Younger Heart Disease Onset Tied to Higher Dementia Risk Among patients with coronary heart disease, younger age of disease onset is significantly associated with an increased risk for all-cause dementia, Alzheimer's disease, and vascular dementia.
  Medscape Medical News, December 11, 2023
• Anticoagulants Safe With Enzyme-Inducing Meds for Epilepsy Co-prescription of enzyme-inducing antiseizure medications is not associated with alteration in direct-acting oral anticoagulant efficacy or safety.
  Medscape Medical News, December 11, 2023
• Sickle Cell Gene Therapy 'Truly Transformative' Patients who received lovo-cel had durable remissions and reductions in vaso-occlusive events, pain crises, and hospitalizations in the longest running gene therapy trial for sickle cell disease.
  Medscape Medical News, December 10, 2023
• Amulet and Watchman Equal for Left Atrial Appendage Closure The Amulet and Watchman FLX devices for left atrial appendage closure produced equivalent results, with about half of patients having residual patency of the appendage at 13 months, a study shows.
  Medscape Medical News, December 08, 2023
• Reducing Albumin Improves Kidney and Heart Function The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.
  Medscape Medical News, December 04, 2023
• ACC/AHA Issue Updated Atrial Fibrillation Guideline The new guideline proposes a new way to classify AF, emphasizes the importance of early rhythm control and lifestyle modification, and gives catheter ablation a Class 1 indication.
  Medscape Medical News, November 30, 2023
• Ohio Group Scores Record Hypertension Control Rates Artificial intelligence is vastly improving blood pressure control at one Midwestern primary care practice. Could your group do the same?
  Medscape Medical News, November 30, 2023
• TCT 2023 Transapical Valve Replacement Relieves Mitral Regurgitation Transapical mitral valve replacement by catheter eliminated mitral regurgitation and improved hemodynamics in a frail high-risk population, results of the SUMMIT trial show.
  Medscape Medical News, November 30, 2023
• Less Severe Strokes With LAA Closure vs DOAC in AF? Atrial fibrillation treated with left atrial appendage closure was associated with ischemic strokes that were less severe than those among similar patients treated with direct oral anticoagulation.
  Medscape Medical News, November 27, 2023
• Perceived Racism Among Black Women a Stroke Risk Factor? The high burden of interpersonal racism experienced by Black women in the US may contribute to racial disparities in stroke incidence, new research suggests.
  Medscape Medical News, November 21, 2023
• PREVENT: AHA's New Risk Calculator Incorporates CKM Health The new cardiovascular disease risk equations start at age 30, include measures of kidney and metabolic health, add heart failure, and remove race from the equations.
  Medscape Medical News, November 20, 2023
• AHA 2023 Single Injection Reduces Blood Pressure for 6 Months The RNA interference therapeutic targeting synthesis of angiotensinogen lowered BP in adults with mild to moderate hypertension for up to 6 months after one dose in the phase 2 KARDIA-1 study.
  Medscape Medical News, November 20, 2023
• Asundexian Phase 3 AF Study Halted for Lack of Efficacy The phase 3 OCEANIC-AF trial of the factor XI inhibitor asundexian (Bayer) has been stopped early owing to inferior efficacy vs apixaban in preventing stroke and systemic embolism in patients with AF.
  Medscape Medical News, November 20, 2023
• Hourly Air Pollution Exposure: A Risk Factor for Stroke Daily exposure to air pollutants has been linked to stroke. A new study investigates the link between hourly exposure to air pollutants and emergency stroke admission shortly after exposure.
  Medscape Medical News, November 17, 2023
• Women Stroke Survivors Fear Disparity in Emergency Care Women with a history of stroke voice their experiences with emergency care, reflecting the challenges they face and the urgent necessity for more equitable healthcare delivery.
  Medscape Medical News, November 16, 2023
• AHA 2023 More Evidence of Better Outcomes With 120 mm Hg BP Target Intensive lowering of blood pressure to a systolic target < 120 mm Hg reduced cardiovascular events among high-risk individuals by 12% vs a target < 140 mm Hg in the ESPRIT trial.
  Medscape Medical News, November 16, 2023
• AF Linked to Dementia, Especially Before Age 65 Years Atrial fibrillation is linked to an increased risk for dementia, particularly when diagnosed before age 65 years, a large population-based study shows.
  Medscape Medical News, November 13, 2023
• AHA 2023 Impressive Bleeding Profile With Factor XI Inhibitor in AF Further details from the phase 2b AZALEA trial of the factor XI inhibitor abelacimab show significant reductions in major and clinically relevant nonmajor bleeding vs rivaroxaban for patients with AF.
  Medscape Medical News, November 13, 2023
• Mobile Stroke Units Tied to Better Outcomes vs EMS Mobile stroke units equipped with clot busting medications, CT machines, and video connections to a physician are linked to better patient outcomes, including stroke avoidance, vs traditional EMS.
  Medscape Medical News, November 13, 2023
• ACR 2023 Pregnancy in Rheumatic Disease Quadruples CVE Risk Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than did pregnant individuals without these conditions.
  Medscape Medical News, November 12, 2023
• AHA 2023 Dropping Aspirin Cuts Bleeding in LVAD Patients A randomized trial evaluating vitamin K therapy with aspirin or placebo with a left ventricular assist device shows avoiding aspirin reduced bleeding without increasing thrombotic risk.
  MDedge News, November 12, 2023
• AHA 2023 Blood Pressure Lowering Reduces Dementia Risk Blood Pressure Lowering Reduces Dementia Risk
  Medscape Medical News, November 12, 2023
• AHA 2023 Apixaban Cuts Stroke but Ups Bleeding in Subclinical AF Further analyses from the ARTESIA study and the previous NOAH-AFNET 6 trial are needed to try to identify groups where the benefit may outweigh the risk, researchers say.
  Medscape Medical News, November 12, 2023
• AHA 2023 Semaglutide 'A New Pathway' to CVD Risk Reduction: SELECT The weight loss drug showed a consistent reduction in major cardiovascular events over a 3-year follow up in patients with a history of heart disease who were overweight or obese.
  Medscape Medical News, November 11, 2023